Cargando…

Is overexpression of TWIST, a transcriptional factor, a prognostic biomarker of head and neck carcinoma? Evidence from fifteen studies

TWIST, a basic helix-loop-helix transcription factor, has been indicated to play a critical role in the progression of numerous malignant disorders. Published data on the significance of TWIST expression in head and neck carcinoma (HNC) risk have yielded conflicting results. Thus, we conducted a qua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuo, Xianlu, Luo, Huanli, Chang, Aoshuang, Li, Dairong, Zhao, Houyu, Zhou, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674799/ https://www.ncbi.nlm.nih.gov/pubmed/26656856 http://dx.doi.org/10.1038/srep18073

Ejemplares similares

SERPINE1 as an Independent Prognostic Marker and Therapeutic Target for Nicotine-Related Oral Carcinoma
por: Guo, Xiaopeng, et al.
Publicado: (2023)

Enhancement of nanoparticle-mediated double suicide gene expression driven by ‘E9-hTERT promoter’ switch in dedifferentiated thyroid cancer cells
por: Chang, Aoshuang, et al.
Publicado: (2021)

MTHFR C677T polymorphism interaction with heavy alcohol consumption increases head and neck carcinoma risk
por: Zhuo, Xianlu, et al.
Publicado: (2015)

Immune-related key gene CLDN10 correlates with lymph node metastasis but predicts favorable prognosis in papillary thyroid carcinoma
por: Xiang, Zhaolan, et al.
Publicado: (2020)

Overexpression of TWIST2 correlates with poor prognosis in Head and Neck Squamous Cell Carcinomas
por: Gasparotto, Daniela, et al.
Publicado: (2011)

Clinicopathological and prognostic significance of Twist overexpression in NSCLC
por: Li, Meng, et al.
Publicado: (2018)

Development of twist‐correction system for radiotherapy of head and neck cancer patients
por: Shimizu, Hidetoshi, et al.
Publicado: (2019)

Multiple paragangliomas of head and neck associated with hepatic paraganglioma: a case report
por: Xiao, Zebin, et al.
Publicado: (2015)

Is MDM2 SNP309 Variation a Risk Factor for Head and Neck Carcinoma?: An Updated Meta-Analysis Based on 11,552 Individuals
por: Zhuo, Xianlu, et al.
Publicado: (2016)

MiR-146a rs2910164 polymorphism and head and neck carcinoma risk: a meta-analysis based on 10 case-control studies
por: Xiang, Zhaolan, et al.
Publicado: (2016)

Overexpressed PLAU and its potential prognostic value in head and neck squamous cell carcinoma
por: Li, Zhexuan, et al.
Publicado: (2021)

The overexpression of salivary cytokeratins as potential diagnostic biomarkers in head and neck squamous cell carcinomas
por: Tang, Kai Dun, et al.
Publicado: (2017)

Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations
por: Ling, Junjun, et al.
Publicado: (2022)

Smoking and gender modify the effect of TWIST on patient survival in head and neck squamous carcinoma
por: Zhu, Yun, et al.
Publicado: (2017)

Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer
por: Parmar, Chintan, et al.
Publicado: (2015)

Fifteen of the best
por: Murray, Anne, 1945-
Publicado: (1992)

Volume Fifteen
Publicado: (1875)

Derivation of a fifteen gene prognostic panel for six cancers
por: Khirade, Mamata F., et al.
Publicado: (2015)

Prognostic Value of the Overexpression of Fatty Acid Metabolism-Related Enzymes in Squamous Cell Carcinoma of the Head and Neck
por: Su, Ying-Wen, et al.
Publicado: (2020)

Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma
por: Ren, He, et al.
Publicado: (2020)

Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients
por: Summerer, I, et al.
Publicado: (2015)

Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients
por: Brøndum, Line, et al.
Publicado: (2017)

DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer
por: Liouta, Galateia, et al.
Publicado: (2023)

Prognostic implications of peritumoral vasculature in head and neck cancer
por: Evans, Michael, et al.
Publicado: (2018)

Olecranon With Concomitant Radial Head Fracture: A Case Series of Fifteen Patients
por: Ditsios, Konstantinos, et al.
Publicado: (2022)

Overexpression of LAPTM4B-35 is a negative prognostic factor in head and neck squamous cell carcinoma
por: Kotowski, Ulana, et al.
Publicado: (2019)

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
por: Chen, Dung-Tsa, et al.
Publicado: (2015)

Fifteen papers on analysis
por: Akopjan, S A, et al.
Publicado: (1968)

Fifteen papers on algebra
por: Bozeck, H, et al.
Publicado: (1965)

Fifteen papers on algebra
por: Ahiezer, N I, et al.
Publicado: (1966)

Fifteen papers on analysis
por: Birman, M Å , et al.
Publicado: (1966)

Fifteen per Cent
Publicado: (1890)

Fifteen Years in Hell!
Publicado: (1857)

Close of Volume Fifteen
Publicado: (1876)

The Committees of Fifteen and Nine
Publicado: (1903)

Antisense inhibition of ATM gene enhances the radiosensitivity of head and neck squamous cell carcinoma in mice
por: Zou, Jian, et al.
Publicado: (2008)

Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies
por: Zhuo, Xianlu, et al.
Publicado: (2016)

E2F4 transcription factor is a prognostic biomarker related to immune infiltration of head and neck squamous cell carcinoma
por: Qi, Li, et al.
Publicado: (2022)

Prognostic biomarker IL17A correlated with immune infiltrates in head and neck cancer
por: Yu, Meng, et al.
Publicado: (2022)

FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma
por: Wu, Qingqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_is41kesqdpqbm86pivdqbokpvg